GeN is a drug discovery and pre-clinical validation biotechnology company with an innovative drug screening technology and a development-stage drug candidate.

View more

PARTNER WITH US TO DEVELOP THE NEXT RARE DISEASE THERAPY

In ten years, we’ve delivered new treatments towards the clinic and FDA approved drugs. We develop partnerships to patent some of these treatments out and to the clinic-ready treatments with Neuren Pharmaceuticals, AMO Pharmaceuticals, Tetra Bio-Pharma and Ovid Pharmaceuticals.

Contact Us

GeN Ltd
Office 7 35-37 Ludgate Hill
London, England
EC4M 7JN

+442071938819

patricia.cogram@genddi.co.uk

diseño alauna